OutcomeImprovementEffect · pTreatmentControl
risk of no clinical status improvement of 2+ WHO-OSCI at ~10 days
14.1% lower · RR 0.86 · p = 0.06
14.1% lowerRR 0.86p = 0.06
73 of 100 (73.0%)
85 of 100 (85.0%)
treatment 73 of 100 (73.0%), control 85 of 100 (85.0%)NNT 8.3
relative time to clinical improvement
33.3% lower · relative time 0.67 · p < 0.0001***
33.3% lowerrelative time 0.67p < 0.0001***
100
100
treatment 100, control 100
risk of no fever reduction by day 3
45.2% lower · RR 0.55 · p < 0.001***
45.2% lowerRR 0.55p < 0.001***
40 of 100 (40.0%)
73 of 100 (73.0%)
treatment 40 of 100 (40.0%), control 73 of 100 (73.0%)NNT 3.0
relative time to resolution of fever
20.0% lower · relative time 0.80 · p = 0.05
20.0% lowerrelative time 0.80p = 0.05
100
100
treatment 100, control 100
risk of no discharge at day 10
69.7% lower · RR 0.30 · p < 0.001***
69.7% lowerRR 0.30p < 0.001***
10 of 100 (10.0%)
33 of 100 (33.0%)
treatment 10 of 100 (10.0%), control 33 of 100 (33.0%)NNT 4.3
risk of no full recovery at day 10
26.7% lower · RR 0.73 · p < 0.001***
26.7% lowerRR 0.73p < 0.001***
66 of 100 (66.0%)
90 of 100 (90.0%)
treatment 66 of 100 (66.0%), control 90 of 100 (90.0%)NNT 4.2
risk of no improvement in lung CT
33.3% lower · RR 0.67 · p = 0.007**
33.3% lowerRR 0.67p = 0.007**
40 of 100 (40.0%)
60 of 100 (60.0%)
treatment 40 of 100 (40.0%), control 60 of 100 (60.0%)NNT 5.0
risk of no viral clearance
90.5% lower · RR 0.10 · p < 0.001***
90.5% lowerRR 0.10p < 0.001***
2 of 100 (2.0%)
21 of 100 (21.0%)
treatment 2 of 100 (2.0%), control 21 of 100 (21.0%)NNT 5.3